相信在白內障手術後,視力一定會更加進步。
使用 Vabysmo(faricimab) / Eylea (aflibercept)注射後注意事項:
在手術中可能產生之併發症並不常見,但下列情況可於手術時或手術後發生:
眼壓增高(青光眼)、或眼壓過低、白內障、飛蚊症、眼球內出血、眼球內發炎、感染或化膿、視網膜裂孔或剝離、未能治癒原視中心點病變,有部分病人手術後黃斑部水腫會持續,及需要多次注射或其他治療……等。
針對此項治療,由於診所單位,健保給付申請不易,因此需自行負擔醫療費用,收費如下~
Vabysmo(faricimab)
- 單次注射 NT 45000
- 半年療程 NT 120000(含3次眼內注射,最多3次視網膜輔助雷射)
-
Eylea (aflibercept)- 單次注射 NT 45000
- 半年療程 NT 120000(含3次眼內注射,最多3次視網膜輔助雷射)
Information for Patients With Macular Edema Following CRVO
If you or a loved one has been diagnosed with Macular Edema following Central Retinal Vein Occlusion (CRVO) or Branch Retinal Vein Occlusion (BRVO) , you are not alone.
Each year, there are approximately 2,000 new cases of Central Retinal Vein Occlusion (CRVO) or Branch Retinal Vein Occlusion (BRVO) in Taiwan.
IMPORTANT PRESCRIBING INFORMATION FOR EYLEA® (aflibercept) INJECTION
EYLEA® (aflibercept) Injection is a prescription medicine approved for the treatment of patients with Macular Edema following CRVO or BRVO. The recommended dose for EYLEA is 2 mg administered by injection in the eye monthly (every 4 weeks).
IMPORTANT SAFETY INFORMATION FOR EYLEA® (aflibercept) INJECTION
The most common side effects reported in patients receiving EYLEA are increased redness in the eye, eye pain, cataract, moving spots in the field of vision, increased pressure in the eye, and vitreous (gel-like substance) detachment.
Serious side effects related to the injection procedure are rare but can occur including infection inside the eye, retinal detachment, cataract, increased pressure in the eye, and vitreous detachment.
參考資料: